Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascaline Boudou-Rouquette

Showing results (61-70 of 122) with videos related to

Pageof 13
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 4, 2019
The impact of body composition parameters on severe toxicity of nivolumabLaure Hirsch, Audrey Bellesoeur, Pascaline Boudou-Rouquette, et al.
Bulletin Du Cancer|February 3, 2016
[Tyrosine kinase inhibiting the VEGF pathway and elderly people: Tolerance, pre-treatment assessment and side effects management]Marie Bretagne, Pascaline Boudou-Rouquette, Olivier Huillard, et al.
International Journal of Surgical Pathology|May 9, 2023
EBV-Positive Inflammatory Follicular Dendritic Cell Sarcoma of the Spleen: Report of an Aggressive Form With Molecular CharacterizationAlistair Baber, Paul Legendre, Patricia Palmic, et al.
Clinical Therapeutics|July 8, 2020
Population Pharmacokinetics of Erlotinib in Patients With Non-small Cell Lung Cancer: Its Application for Individualized Dosing Regimens in Older PatientsEvelina Cardoso, Monia Guidi, Nihel Khoudour, et al.
Nutrients|March 11, 2023
Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer TreatmentAnne-Laure Couderc, Evelyne Liuu, Pascaline Boudou-Rouquette, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 25, 2020
Postoperative Outcome of Surgery with Pancreatic Resection for Retroperitoneal Soft Tissue Sarcoma: Results of a Retrospective Bicentric Analysis on 50 Consecutive PatientsMeredith Flacs, Matthieu Faron, Olivier Mir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2022
A Two-Step Frailty Assessment Strategy in Older Patients With Solid Tumors: A Decision Curve AnalysisAdolfo González Serrano, Marie Laurent, Thomas Barnay, et al.
Fundamental & Clinical Pharmacology|October 22, 2017
Drug monitoring of sunitinib in patients with advanced solid tumors: a monocentric observational French studyLuc Cabel, Benoit Blanchet, Audrey Thomas-Schoemann, et al.
Investigational New Drugs|April 12, 2017
Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patientsValentine Heidelberger, François Goldwasser, Nora Kramkimel, et al.
Plos One|August 23, 2012
Early sorafenib-induced toxicity is associated with drug exposure and UGTIA9 genetic polymorphism in patients with solid tumors: a preliminary studyPascaline Boudou-Rouquette, Céline Narjoz, Jean Louis Golmard, et al.
Pageof 13

Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|December 4, 2019
The impact of body composition parameters on severe toxicity of nivolumabLaure Hirsch, Audrey Bellesoeur, Pascaline Boudou-Rouquette, et al.
Bulletin Du Cancer|February 3, 2016
[Tyrosine kinase inhibiting the VEGF pathway and elderly people: Tolerance, pre-treatment assessment and side effects management]Marie Bretagne, Pascaline Boudou-Rouquette, Olivier Huillard, et al.
International Journal of Surgical Pathology|May 9, 2023
EBV-Positive Inflammatory Follicular Dendritic Cell Sarcoma of the Spleen: Report of an Aggressive Form With Molecular CharacterizationAlistair Baber, Paul Legendre, Patricia Palmic, et al.
Clinical Therapeutics|July 8, 2020
Population Pharmacokinetics of Erlotinib in Patients With Non-small Cell Lung Cancer: Its Application for Individualized Dosing Regimens in Older PatientsEvelina Cardoso, Monia Guidi, Nihel Khoudour, et al.
Nutrients|March 11, 2023
Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer TreatmentAnne-Laure Couderc, Evelyne Liuu, Pascaline Boudou-Rouquette, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 25, 2020
Postoperative Outcome of Surgery with Pancreatic Resection for Retroperitoneal Soft Tissue Sarcoma: Results of a Retrospective Bicentric Analysis on 50 Consecutive PatientsMeredith Flacs, Matthieu Faron, Olivier Mir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2022
A Two-Step Frailty Assessment Strategy in Older Patients With Solid Tumors: A Decision Curve AnalysisAdolfo González Serrano, Marie Laurent, Thomas Barnay, et al.
Fundamental & Clinical Pharmacology|October 22, 2017
Drug monitoring of sunitinib in patients with advanced solid tumors: a monocentric observational French studyLuc Cabel, Benoit Blanchet, Audrey Thomas-Schoemann, et al.
Investigational New Drugs|April 12, 2017
Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patientsValentine Heidelberger, François Goldwasser, Nora Kramkimel, et al.
Plos One|August 23, 2012
Early sorafenib-induced toxicity is associated with drug exposure and UGTIA9 genetic polymorphism in patients with solid tumors: a preliminary studyPascaline Boudou-Rouquette, Céline Narjoz, Jean Louis Golmard, et al.
Pageof 13